{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T20:27:07Z","timestamp":1793910427219,"version":"4.8.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"German Ministry of Health"},{"name":"German Ministry of Education and Research"},{"name":"Robert Koch Institute"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12879-017-2461-2","type":"journal-article","created":{"date-parts":[[2017,5,19]],"date-time":"2017-05-19T09:47:38Z","timestamp":1495187258000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Varicella-zoster virus seroprevalence in children and adolescents in the pre-varicella vaccine era, Germany"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9300-2563","authenticated-orcid":false,"given":"Miriam","family":"Wiese-Posselt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anette","family":"Siedler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Mankertz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Sauerbrei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hartmut","family":"Hengel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ole","family":"Wichmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Poethko-M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,5,19]]},"reference":[{"issue":"9544","key":"2461_CR1","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/S0140-6736(06)69561-5","volume":"368","author":"U Heininger","year":"2006","unstructured":"Heininger U, Seward JF. Varicella. Lancet. 2006;368(9544):1365\u201376.","journal-title":"Lancet"},{"issue":"2","key":"2461_CR2","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/INF.0b013e3181586665","volume":"27","author":"JG Liese","year":"2008","unstructured":"Liese JG, Grote V, Rosenfeld E, Fischer R, Belohradsky BH, v Kries R, Group EVS. The burden of varicella complications before the introduction of routine varicella vaccination in Germany. Pediatr Infect Dis J. 2008;27(2):119\u201324.","journal-title":"Pediatr Infect Dis J"},{"key":"2461_CR3","first-page":"235","volume":"30","author":"German-Standing-Committee-on-Vacccination","year":"2004","unstructured":"German-Standing-Committee-on-Vacccination. Empfehlungen der St\u00e4ndigen Impfkommission (STIKO) am Robert Koch Institut\/Stand: Juli 2004. Epidemiol Bull. 2004;30:235\u201350.","journal-title":"Epidemiol Bull"},{"key":"2461_CR4","first-page":"279","volume":"30","author":"German-Standing-Committee-on-Vacccination","year":"2009","unstructured":"German-Standing-Committee-on-Vacccination. Empfehlungen der St\u00e4ndigen Impfkommission (STIKO) am Robert Koch Institut\/Stand: Juli 2009. Epidemiol Bull. 2009;30:279\u201398.","journal-title":"Epidemiol Bull"},{"issue":"9","key":"2461_CR5","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1007\/s00103-013-1789-z","volume":"56","author":"A Siedler","year":"2013","unstructured":"Siedler A, Hecht J, Rieck T, Tolksdorf K, Hengel H. Varicella vaccination in Germany. A provisional appraisal in the context of MMR vaccination. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz. 2013;56(9):1313\u201320.","journal-title":"Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz"},{"key":"2461_CR6","first-page":"1","volume":"1","author":"German-Standing-Committee-on-Vacccination","year":"2013","unstructured":"German-Standing-Committee-on-Vacccination. Stellungnahme der St\u00e4ndigen Impfkommission (STIKO): Evaluation der Varizellen-Impfempfehlung durch die STIKO. Epidemiol Bull. 2013;1:1\u20135.","journal-title":"Epidemiol Bull"},{"issue":"9","key":"2461_CR7","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1097\/INF.0b013e3181e2817f","volume":"29","author":"M Spackova","year":"2010","unstructured":"Spackova M, Muehlen M, Siedler A. Complications of varicella after implementation of routine childhood varicella vaccination in Germany. Pediatr Infect Dis J. 2010;29(9):884\u20136.","journal-title":"Pediatr Infect Dis J"},{"key":"2461_CR8","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jpeds.2016.02.040","volume":"173","author":"A Siedler","year":"2016","unstructured":"Siedler A, Rieck T, Tolksdorf K. Strong additional effect of a second Varicella vaccine dose in children in Germany, 2009\u20132014. J Pediatr. 2016;173:202\u20136. e202","journal-title":"J Pediatr"},{"issue":"3","key":"2461_CR9","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/0264-410X(90)90042-K","volume":"8","author":"N Begg","year":"1990","unstructured":"Begg N, Miller E. Role of epidemiology in vaccine policy. Vaccine. 1990;8(3):180\u20139.","journal-title":"Vaccine"},{"issue":"3","key":"2461_CR10","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0891-5520(05)70311-1","volume":"10","author":"DL Krah","year":"1996","unstructured":"Krah DL. Assays for antibodies to varicella-zoster virus. Infect Dis Clin N Am. 1996;10(3):507\u201327.","journal-title":"Infect Dis Clin N Am"},{"key":"2461_CR11","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/1471-2458-8-196","volume":"8","author":"BM Kurth","year":"2008","unstructured":"Kurth BM, Kamtsiuris P, Holling H, Schlaud M, Dolle R, Ellert U, Kahl H, Knopf H, Lange M, Mensink GB, et al. The challenge of comprehensively mapping children's health in a nation-wide health survey: design of the German KiGGS-study. BMC Public Health. 2008;8:196.","journal-title":"BMC Public Health"},{"key":"2461_CR12","unstructured":"Euroimmun-Medizinische-Labordiagnostika: Anti-VZV-ELISA (IgG): product description. \nhttps:\/\/www.euroimmun.com\/products\/indications\/infektions-serologie\/immunittsbestimmung.html\n\n. 2016. Accessed 25 Aug 2016."},{"issue":"1\u20132","key":"2461_CR13","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0264-410X(01)00276-6","volume":"20","author":"P Wutzler","year":"2001","unstructured":"Wutzler P, Farber I, Wagenpfeil S, Bisanz H, Tischer A. Seroprevalence of varicella-zoster virus in the German population. Vaccine. 2001;20(1\u20132):121\u20134.","journal-title":"Vaccine"},{"issue":"8","key":"2461_CR14","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1128\/CVI.00183-12","volume":"19","author":"A Sauerbrei","year":"2012","unstructured":"Sauerbrei A, Schafler A, Hofmann J, Schacke M, Gruhn B, Wutzler P. Evaluation of three commercial varicella-zoster virus IgG enzyme-linked immunosorbent assays in comparison to the fluorescent-antibody-to-membrane-antigen test. Clinical and vaccine immunology: CVI. 2012;19(8):1261\u20138.","journal-title":"Clinical and vaccine immunology: CVI"},{"issue":"1","key":"2461_CR15","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00103-012-1583-3","volume":"56","author":"T Lampert","year":"2013","unstructured":"Lampert T, Kroll LE, Muters S, Stolzenberg H. Measurement of the socioeconomic status within the German health update 2009 (GEDA). Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz. 2013;56(1):131\u201343.","journal-title":"Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz"},{"issue":"45","key":"2461_CR16","doi-asserted-by":"crossref","first-page":"7866","DOI":"10.1016\/j.vaccine.2007.07.036","volume":"25","author":"A Nardone","year":"2007","unstructured":"Nardone A, de Ory F, Carton M, Cohen D, van Damme P, Davidkin I, Rota MC, de Melker H, Mossong J, Slacikova M, et al. The comparative sero-epidemiology of varicella zoster virus in 11 countries in the European region. Vaccine. 2007;25(45):7866\u201372.","journal-title":"Vaccine"},{"issue":"18","key":"2461_CR17","doi-asserted-by":"crossref","first-page":"3946","DOI":"10.1016\/j.vaccine.2006.02.017","volume":"24","author":"H Melker de","year":"2006","unstructured":"de Melker H, Berbers G, Hahne S, Rumke H, van den Hof S, de Wit A, Boot H. The epidemiology of varicella and herpes zoster in The Netherlands: implications for varicella zoster virus vaccination. Vaccine. 2006;24(18):3946\u201352.","journal-title":"Vaccine"},{"issue":"44","key":"2461_CR18","doi-asserted-by":"crossref","first-page":"5127","DOI":"10.1016\/j.vaccine.2013.08.029","volume":"31","author":"A Lier van","year":"2013","unstructured":"van Lier A, Smits G, Mollema L, Waaijenborg S, Berbers G, van der Klis F, Boot H, Wallinga J, de Melker H. Varicella zoster virus infection occurs at a relatively young age in The Netherlands. Vaccine. 2013;31(44):5127\u201333.","journal-title":"Vaccine"},{"key":"2461_CR19","unstructured":"Statistisches-Bundesamt: Kinder in Tageseinrichtungen: Bundesl\u00e4nder, Stichtag, Altersgruppen. \nhttps:\/\/www-genesis.destatis.de\/genesis\/online\/data;jsessionid=3EA435F18B26C98679C70B0E75C53821.tomcat_GO_1_3?operation=abruftabellenVerzeichnis\n\n. Accessed 26 Aug 2016."},{"key":"2461_CR20","unstructured":"European-Commission: Use of childcare in the EU Member States and progress towards the Barcelona targets. \nhttp:\/\/eacea.ec.europa.eu\/education\/eurydice\/documents\/key_data_series\/166EN.pdf\n\n, Accessed 26 Aug 2016."},{"issue":"2","key":"2461_CR21","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1177\/2051013613515621","volume":"2","author":"O Papaloukas","year":"2014","unstructured":"Papaloukas O, Giannouli G, Papaevangelou V. Successes and challenges in varicella vaccine. Ther Adv Vaccines. 2014;2(2):39\u201355.","journal-title":"Ther Adv Vaccines"},{"issue":"12","key":"2461_CR22","doi-asserted-by":"crossref","first-page":"3594","DOI":"10.4161\/hv.34426","volume":"10","author":"A Siedler","year":"2014","unstructured":"Siedler A, Dettmann M. Hospitalization with varicella and shingles before and after introduction of childhood varicella vaccination in Germany. Human vaccines & immunotherapeutics. 2014;10(12):3594\u2013600.","journal-title":"Human vaccines & immunotherapeutics"},{"issue":"1","key":"2461_CR23","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1542\/peds.2013-4251","volume":"134","author":"R Baxter","year":"2014","unstructured":"Baxter R, Tran TN, Ray P, Lewis E, Fireman B, Black S, Shinefield HR, Coplan PM, Saddier P. Impact of vaccination on the epidemiology of varicella: 1995\u20132009. Pediatrics. 2014;134(1):24\u201330.","journal-title":"Pediatrics"},{"issue":"7","key":"2461_CR24","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1128\/CVI.00131-10","volume":"17","author":"SA Plotkin","year":"2010","unstructured":"Plotkin SA. Correlates of protection induced by vaccination. Clinical and vaccine immunology : CVI. 2010;17(7):1055\u201365.","journal-title":"Clinical and vaccine immunology : CVI"},{"issue":"5","key":"2461_CR25","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1086\/501900","volume":"22","author":"L Saiman","year":"2001","unstructured":"Saiman L, LaRussa P, Steinberg SP, Zhou J, Baron K, Whittier S, Della-Latta P, Gershon AA. Persistence of immunity to varicella-zoster virus after vaccination of healthcare workers. Infect Control Hosp Epidemiol. 2001;22(5):279\u201383.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"7","key":"2461_CR26","first-page":"1766","volume":"12","author":"J Horn","year":"2016","unstructured":"Horn J, Karch A, Damm O, Kretzschmar ME, Siedler A, Ultsch B, Weidemann F, Wichmann O, Hengel H, Greiner W, et al. Current and future effects of varicella and herpes zoster vaccination in Germany - insights from a mathematical model in a country with universal varicella vaccination. Human vaccines & immunotherapeutics. 2016;12(7):1766\u201376.","journal-title":"Human vaccines & immunotherapeutics"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-017-2461-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,5,19]],"date-time":"2017-05-19T09:47:59Z","timestamp":1495187279000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-017-2461-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,19]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["2461"],"URL":"https:\/\/doi.org\/10.1186\/s12879-017-2461-2","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,19]]},"article-number":"356"}}